Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Andrea De Luca, Sara Lodi, Martin Fisher, Andrew Phillips, Jade Ghosn, Ruslan Malyuta, Robert Zangerle, Santiago Moreno, Philippe Vanhems, Faroudy Boufassa, Marguerite Guiguet, Kholoud Porter

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

6 Citazioni (Scopus)

Abstract

The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
Lingua originaleEnglish
pagine (da-a)e78642-e78642
RivistaPLoS One
Volume8
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • CD4
  • drugs
  • hiv
  • markers

Fingerprint Entra nei temi di ricerca di 'Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection'. Insieme formano una fingerprint unica.

Cita questo